Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Developing a managed care-pharmaceutical research partnership.

B E Lewis1, R Kimmelheim, K Gondek

  • 1Focus Managed Research, Inc., Philadelphia, PA, USA.

Managed Care Interface
|June 3, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changes in the intestinal microbiota of broiler chicken induced by dietary supplementation of the diatomite-bentonite mixture.

BMC veterinary research·2025
Same author

Mobility of heavy metals in sandy soil after application of composts produced from maize straw, sewage sludge and biochar - Discussion of Moussavi et al. - JEMA-D-18-00677.

Journal of environmental management·2018
Same author

Mobility of heavy metals in sandy soil after application of composts produced from maize straw, sewage sludge and biochar.

Journal of environmental management·2018
Same author

A Case of Porro's Hysterectomy.

The Indian medical gazette·2017
Same author

Anti-tumor effects of peptide analogs targeting neuropeptide hormone receptors on mouse pheochromocytoma cells.

Molecular and cellular endocrinology·2012
Same author

Can the functional assessment of multiple sclerosis adapt to changing needs? A psychometric validation in patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2011
Same journal

Changes in hospital readmissions for diabetes-related conditions. Differences by payer.

Managed care interface·2008
Same journal

Heart disease and managed care.

Managed care interface·2008
Same journal

A conversation with James K. Min, MD.

Managed care interface·2008
Same journal

Acute coronary syndromes.

Managed care interface·2008
Same journal

Improving outcomes in cardiovascular disease.

Managed care interface·2008
Same journal

The effect for oncology of the national coverage determination for erythropoiesis-stimulating agents.

Managed care interface·2008
See all related articles

Managed care organizations increasingly require cost-effectiveness data for new medications. This study details a partnership assessing a new osteoarthritis drug

Area of Science:

  • Pharmacoeconomics
  • Health Services Research

Background:

  • Managed care organizations (MCOs) are increasingly demanding evidence of cost-effectiveness for new pharmaceutical products before formulary inclusion.
  • Assessing the economic value of novel medications is crucial for MCOs' decision-making processes.

Purpose of the Study:

  • To examine a collaborative research partnership between a pharmaceutical company and 14 MCOs.
  • To evaluate the cost-effectiveness of a new medication for osteoarthritis (OA).

Main Methods:

  • The study involved a partnership between a pharmaceutical manufacturer and 14 MCOs.
  • A detailed study protocol was developed to guide research activities.
  • Data collection and analysis focused on the cost-effectiveness of the OA medication.

Related Experiment Videos

Main Results:

  • The research partnership facilitated the assessment of the new OA medication's economic value.
  • The study protocol outlined the methodology for evaluating cost-effectiveness.
  • Specific research activities were undertaken to gather relevant data.

Conclusions:

  • Collaborative research partnerships can effectively evaluate the cost-effectiveness of new drugs.
  • Evidence generated through such partnerships aids MCOs in formulary decisions.
  • This approach supports informed decision-making regarding pharmaceutical adoption.